Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15815 articles
Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer.
Exosomal miR-17-92a cluster expression level in serum was correlated with the recurrence of CRC.
»
02/22/15
KIAA1324 suppresses gastric cancer progression by inhibiting the oncoprotein GRP78.
Identified GRP78 (glucose-regulated protein 78kDa) as a KIAA1324 binding partner.
»
06/06/15
BCL6 induces EMT by promoting the ZEB1-mediated transcription repression of E-cadherin in breast cancer cells.
Targeting BCL6 has therapeutic potential against the development and progression of breast cancer.
»
04/13/15
Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer.
BRCA1 cytosolic mislocalisation promotes breast cancer metastasis.
»
03/25/15
The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study
In ER-stratified analyses, HER2 positive DCIS was associated with lower risk of IBCR among women with ER negative DCIS.
»
06/11/15
CXCL5/CXCR2 axis promotes bladder cancer cell migration and invasion by activating PI3K/AKT-induced upregulation of MMP2/MMP9.
CXCL5 contributes to BCa migration and invasion by binding to its receptor, CXCR2.
»
02/11/15
Fibroblast ERα promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment.
Newly identified ERα-stimulated CCL1 and IL-6 signal pathways.
»
05/20/15
MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN
Ectopic expression of miR-29b decreased cell proliferation, migration and invasion abilities of NSCLC cells.
»
06/11/15
STUMP un“stumped”: anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
Immunostains showed diffuse positivity for
ALK1
expression.
»
06/11/15
Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression
Two genes identified as a novel breast cancer biomarker gene set.
»
06/18/15
< Prev
Next >